Investor Overview

Investor Presentation
Financial News
Dec 21, 2018

/NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES./ TORONTO and HOUSTON, TX, Dec. 21, 2018 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company

Dec 14, 2018

NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES. TORONTO, ON and HOUSTON, TX, December 14, 2018 – Medicenna Therapeutics Corp. ("Medicenna" or the...

Dec 5, 2018

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received US$1,224,540 (approximately,...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Monday, January 7, 2019 - Wednesday, January 9, 2019

Biotech Showcase 2019
Hilton San Francisco Union Square
San Francisco, CA 94102 USA

Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
Mike Cole, MZ Group 
1-949-259-4988
Email Alerts
* Required Fields